Literature DB >> 29221289

Features of rheumatic mitral valves and a grading system to identify suitable repair cases in China.

Tiange Luo1, Jie Han1, Xu Meng1.   

Abstract

BACKGROUND: We aimed to assess the pathological characteristics of rheumatic mitral valve disease in Chinese patients and formulate a pathological grading system to identify cases suitable for rheumatic mitral valve repair (rMVP).
METHODS: Nearly 5 years of follow-up data on patients who underwent rMVP were analysed. A Kaplan-Meier survival curve for freedom from reoperation and valve failure was constructed. A pathological grading system of rheumatic mitral valve lesions (PGSRMVL) was developed based on the pathological characteristics of rheumatic mitral valve disease and tested by receiver operating characteristics (ROCs) curve analysis. Predictors of endpoints for rheumatic repair were analysed.
RESULTS: From January 2012 to June 2016, 179 patients underwent rMVP in our centre. The mean follow-up duration was 24±14 months. A left atrial anterior and posterior diameter >60 mm was an independent predictor for the 16 endpoints [hazard ratio (HR) =3.884, P=0.029]. Between 2015 and 2016, 126 consecutive pathological characteristics of rheumatic mitral valve were evaluated (61 and 65 repair and replacement cases, respectively). The ROCs area under the curve was 0.891 for the correlation between the pathological score and successful repair (cut-off point, 17.5; sensitivity, 78%; specificity, 85.2%). Seven lesions had higher ratios in the replacement group than the repair group. Commissural fusion/calcification and main chordae tendineae fusion/calcification were the most common severe pathological lesions.
CONCLUSIONS: The main pathological characteristics of rheumatic mitral valve disease in Chinese patients are commissure and sub-valvular apparatus lesions. Most patients can be appropriately treated via commissurotomy and leaflet thinning. Severe calcification of the commissure and sub-valvular apparatus can considerably decrease the odds of a successful repair. The median follow-up results of rheumatic mitral repair are considered satisfactory for the pathological characteristics in Chinese patients.

Entities:  

Keywords:  Chinese; Rheumatic; pathological; repair

Year:  2017        PMID: 29221289      PMCID: PMC5708488          DOI: 10.21037/jtd.2017.08.121

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  25 in total

Review 1.  Rheumatic heart disease.

Authors:  Eloi Marijon; Mariana Mirabel; David S Celermajer; Xavier Jouven
Journal:  Lancet       Date:  2012-03-10       Impact factor: 79.321

Review 2.  Preservation of the mitral valve apparatus: evidence synthesis and critical reappraisal of surgical techniques.

Authors:  Thanos Athanasiou; Andre Chow; Christopher Rao; Omer Aziz; Fotios Siannis; Ayyaz Ali; Ara Darzi; Francis Wells
Journal:  Eur J Cardiothorac Surg       Date:  2008-01-14       Impact factor: 4.191

3.  Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China.

Authors:  Fang-Zhou Liu; Yu-Mei Xue; Hong-Tao Liao; Xian-Zhang Zhan; Hui-Ming Guo; Huan-Lei Huang; Xian-Hong Fang; Wei Wei; Fang Rao; Hai Deng; Yang Liu; Wei-Dong Lin; Shu-Lin Wu
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

4.  Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era.

Authors:  Rakesh M Suri; Hartzell V Schaff; Joseph A Dearani; Thoralf M Sundt; Richard C Daly; Charles J Mullany; Maurice Enriquez-Sarano; Thomas A Orszulak
Journal:  Ann Thorac Surg       Date:  2006-09       Impact factor: 4.330

5.  Mitral valve repair in a predominantly rheumatic population. Long-term results.

Authors:  S K Choudhary; S Talwar; B Dubey; A Chopra; A Saxena; A S Kumar
Journal:  Tex Heart Inst J       Date:  2001

6.  Is rheumatic mitral valve repair still a feasible alternative?: indications, technique, and results.

Authors:  Ihsan Bakir; Burak Onan; Ismihan Selen Onan; Mehmet Gul; Nevzat Uslu
Journal:  Tex Heart Inst J       Date:  2013

Review 7.  Valvular aspects of rheumatic heart disease.

Authors:  Boglarka Remenyi; Ahmed ElGuindy; Sidney C Smith; Magdi Yacoub; David R Holmes
Journal:  Lancet       Date:  2016-03-26       Impact factor: 79.321

8.  Echocardiographic evaluation of mitral durability following valve repair in rheumatic mitral valve disease: impact of Maze procedure.

Authors:  Gwan Sic Kim; Chee Hoon Lee; Joon Bum Kim; Sung-Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2012-11-21       Impact factor: 5.209

Review 9.  Long-term outcomes of mitral valve repair versus replacement for degenerative disease: a systematic review.

Authors:  Christian A McNeely; Christina M Vassileva
Journal:  Curr Cardiol Rev       Date:  2015

Review 10.  Management of antithrombotic therapy during cardiac implantable device surgery.

Authors:  Ahmed AlTurki; Riccardo Proietti; David H Birnie; Vidal Essebag
Journal:  J Arrhythm       Date:  2016-01-18
View more
  3 in total

1.  Repair versus replacement of mitral valves in cases of severe rheumatic mitral stenosis: mid-term clinical outcomes.

Authors:  Yuqing Jiao; Tiange Luo; Haibo Zhang; Jie Han; Yan Li; Yixin Jia; Shuai Zheng; Xu Meng
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

2.  Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy.

Authors:  Tiange Luo; Xu Meng
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

Review 3.  Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease.

Authors:  Jean Jacques Noubiap; Ulrich Flore Nyaga; Aude Laetitia Ndoadoumgue; Jan René Nkeck; Anderson Ngouo; Jean Joel Bigna
Journal:  Glob Heart       Date:  2020-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.